Dr. Jose Alemar, MD

Dr. Alemar practices at American Oncology Partners PA in Asheville, North Carolina.

Dr. Alemar's NPI, 1154302156, was assigned on November 8, 2005. Dr. Alemar graduated from University of Puerto Rico, Medical Sciences Campus in 1999. Dr. Alemar holds Florida license ME84938.

Dr. Alemar's primary practice is American Oncology Partners PA, at 551 Brevard Rd, Asheville, NC 28806 in Buncombe County. The practice phone is (614) 383-6000.

Dr. Alemar's primary practice is American Oncology Partners PA in Asheville, North Carolina. Dr. Alemar is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is Zangmeister Cancer Center. Dmand AI also links Dr. Alemar to 4 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alemar practices, 7 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Alemar's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Alemar is board certified in hematology by the American Board of Internal Medicine. Dr. Alemar is licensed in Florida.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Alemar treats.

CMS data shows 122,190 Medicare services from Dr. Alemar across 70 procedure codes in 2024, for 480 Medicare patients. Medicare paid $1,372,790 for them.

CMS counts 480 Medicare patients who saw Dr. Alemar in 2024. The largest group is 65 to 74, with 199 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alemar's median patient age at 71, with 52% women.

In 2024, Dr. Alemar wrote 1,287 Medicare Part D claims for 234 patients. 73% of them were for generic drugs. CMS names the drug for 867 of them, across 34 drugs with 11 or more claims each, at $2,036,356 in total drug cost. In 2023, CMS named 260 claims across 13 drugs.

Dr. Alemar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Alemar, published from 2013 to 2016. 2013 was the busiest year, with 2. Dr. Alemar's most frequent co-authors are Brooke E. Daniel, MD, John D. Hainsworth, MD and Robyn R. Young, MD.

CMS Open Payments shows 680 general payments to Dr. Alemar from 82 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 45% of the total. Incyte Corporation paid the most, $11,717.

Dmand AI lists 3 awards for Dr. Alemar, most recently CMS Stage 1 EHR in 2014.

Dr. Alemar graduated from University of Puerto Rico, Medical Sciences Campus in 1999.

Dr. Alemar is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.